Loading market intelligence…
Oak Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Oak Bio is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Position by illustrative valuation within the tracked sector.
Explore sector ↗| 2026-05-04 | Series B | $68M | $7.8B | Civic Innovation Fund | Horizon Growth, Pacific Foundry Ventures | Demo · Unverified |
| 2025-04-12 | Series A | $22M | Not disclosed | Civic Innovation Fund | Horizon Growth, Pacific Foundry Ventures | Demo · Unverified |
| 2024-01-08 | Seed | $5M | Not disclosed | Civic Innovation Fund | Horizon Growth, Pacific Foundry Ventures | Demo · Unverified |
Illustrative founding year
| Helix Discovery | Biotech | $36.1B | $483M | Growth |
| Cellular Atlas | Biotech | $16.3B | $204M | Series C+ |
| Cedar Bio | Biotech | $10.5B | $129M | Series C+ |
| Juniper Bio | Biotech | $6.2B | $75M | Series B |
All metrics on this profile originate in the SVI illustrative dataset. Published and retrieved Sep 18, 2026. Last verified: not verified. No original external publication exists for synthetic records.
Demo dataset · Sep 18, 2026